Nras loss induces metastatic conversion of Rb1-deficient neuroendocrine thyroid tumor

Mutations in the gene encoding the retinoblastoma tumor suppressor predispose humans and mice to tumor development. Here we have assessed the effect of Nras loss on tumor development in Rb1 heterozygous mice. Loss of one or two Nras alleles is shown to significantly reduce the severity of pituitary tumors arising in Rb1+/− animals by enhancing their differentiation. By contrast, C-cell thyroid adenomas occurring in Rb1+/− mice progress to metastatic medullary carcinomas after loss of Nras. In Rb1+/−Nras+/− animals, distant medullary thyroid carcinoma metastases are associated with loss of the remaining wild-type Nras allele. Loss of Nras in Rb1-deficient C cells results in elevated Ras homolog family A (RhoA) activity, and this is causally linked to the invasiveness and metastatic behavior of these cells. These findings suggest that the loss of the proto-oncogene Nras in certain cellular contexts can promote malignant tumor progression.

[1]  R. Kucherlapati,et al.  The murine N-ras gene is not essential for growth and development. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[2]  G. Brodeur,et al.  Low frequency of ras gene mutations in neuroblastomas, pheochromocytomas, and medullary thyroid cancers. , 1991, Cancer research.

[3]  B. Contreras,et al.  Rb and N-ras Function Together To Control Differentiation in the Mouse , 2003, Molecular and Cellular Biology.

[4]  Y. Wong,et al.  Gz signaling: emerging divergence from Gi signaling , 2001, Oncogene.

[5]  M. Vooijs,et al.  Developmental defects and tumor predisposition in Rb mutant mice , 1999, Oncogene.

[6]  A. Bradley,et al.  Heterozygous Rb-1 delta 20/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. , 1994, Oncogene.

[7]  R. Kucherlapati,et al.  K-ras is an essential gene in the mouse with partial functional overlap with N-ras. , 1997, Genes & development.

[8]  S. Mills Neuroectodermal Neoplasms of the Head and Neck with Emphasis on Neuroendocrine Carcinomas , 2002, Modern Pathology.

[9]  Y. Fujimoto,et al.  C cell adenoma of the thyroid: a rare but distinct clinical entity. , 1988, Surgery.

[10]  A. Berns,et al.  Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. , 2003, Cancer cell.

[11]  Anne White,et al.  ACTH precursors: biological significance and clinical relevance , 1998, Clinical endocrinology.

[12]  M. Ewen,et al.  The Retinoblastoma Protein Is Linked to the Activation of Ras , 1999, Molecular and Cellular Biology.

[13]  R. Weinberg,et al.  Effects of an Rb mutation in the mouse , 1992, Nature.

[14]  T. Jacks,et al.  Cooperative tumorigenic effects of germline mutations in Rb and p53 , 1994, Nature Genetics.

[15]  D. Bar-Sagi,et al.  Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation , 1985, Cell.

[16]  Ming You,et al.  Wildtype Kras2 can inhibit lung carcinogenesis in mice , 2001, Nature Genetics.

[17]  Erik Sahai,et al.  Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis , 2003, Nature Cell Biology.

[18]  E. Fearon Human cancer syndromes: clues to the origin and nature of cancer. , 1997, Science.

[19]  A. Ogura,et al.  Sarcoma viruses carrying ras oncogenes induce differentiation-associated properties in a neuronal cell line , 1985, Nature.

[20]  J. Minna,et al.  Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines. , 1991, Oncogene.

[21]  W. Kiosses,et al.  Regulation of the small GTP‐binding protein Rho by cell adhesion and the cytoskeleton , 1999, The EMBO journal.

[22]  M. Beskid C cell adenoma of the human thyroid gland. , 1979, Oncology.

[23]  U. Mohr International Classification of Rodent Tumors. The Mouse , 2001, Springer Berlin Heidelberg.

[24]  D. Harrison,et al.  Effects of heterozygosity for the Rb-1t19neo allele in the mouse. , 1995, Oncogene.

[25]  J. Westwick,et al.  Integrin-specific activation of Rac controls progression through the G(1) phase of the cell cycle. , 2001, Molecular cell.

[26]  Chiaki Takahashi,et al.  Genetic Interaction between Rb and K-ras in the Control of Differentiation and Tumor Suppression , 2004, Molecular and Cellular Biology.

[27]  T. Jacks,et al.  Cell type-specific effects of Rb deletion in the murine retina. , 2004, Genes & development.

[28]  S. Baylin,et al.  Introduction of v-Ha-ras oncogene induces differentiation of cultured human medullary thyroid carcinoma cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[29]  B. Nelkin,et al.  Insertion of the v-Ha-ras oncogene induces differentiation of calcitonin-producing human small cell lung cancer. , 1989, The Journal of clinical investigation.